ISREC – Institut Suisse de Recherche Expérimentale sur le Cancer

Can Aztekin receives Branco Weiss Fellowship

Published:06.09.22 — The Branco Weiss Fellowship-Society in Science has selected ELISIR Scholar Dr Can Aztekin at EPFL as one of its new Fellows in 2022.

Breakthrough study of hormone “crosstalk” in breast cancer

Published:16.06.22 — Scientists led by EPFL have successfully engrafted breast cancer cells on mice, allowing them to study in vivo the cross-talk between the estrogen and progesterone receptors that hampers hormone therapies. Their findings suggest that endocrine therapy may need to be personalized, and that abrogating progesterone receptor expression can be a therapeutic option.

The delicate dance of developmental genes

Published:29.10.21 — Using CRISPR technology, researchers at EPFL and the University of Geneva have uncovered the complex dance of genes involved in embryonic development.